問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Neurology

更新時間:2023-09-19

吳逸如
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

5Cases

2025-10-15 - 2032-12-31

Phase III

Not yet recruiting
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease
  • Condition/Disease

    Parkinson's Disease

  • Test Drug

    injections

Participate Sites
5Sites

Recruiting5Sites

2025-05-01 - 2027-12-31

Phase IV

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2017-04-12 - 2017-04-12

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2023-06-30 - 2024-01-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2014-08-01 - 2017-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites